Home > Insider Trading > Filing (0001179110-18-006501)

Filing Details

Accession Number:: 0001179110-18-006501
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-05-09 19:21:51
Reporting Period:: 2018-05-07

Accepted Time:: 2018-05-09 19:21:51
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
815094	Abiomed Inc	ABMD	Surgical & Medical Instruments & Apparatus (3841)	042743260

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1456804	G Michael Howley	C/O Abiomed, Inc. 22 Cherry Hill Drive Danvers MA 01923	Vp, Global Sales & Marketing	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock, $.01 Par Value	Acquisiton	2018-05-07	17,500	$21.55	64,257	No	4	M	Direct
Common Stock, $.01 Par Value	Disposition	2018-05-07	800	$345.09	63,457	No	4	S	Direct
Common Stock, $.01 Par Value	Disposition	2018-05-07	2,551	$346.13	60,906	No	4	S	Direct
Common Stock, $.01 Par Value	Disposition	2018-05-07	4,101	$347.03	56,805	No	4	S	Direct
Common Stock, $.01 Par Value	Disposition	2018-05-07	2,100	$348.06	54,705	No	4	S	Direct
Common Stock, $.01 Par Value	Disposition	2018-05-07	5,236	$349.08	49,469	No	4	S	Direct
Common Stock, $.01 Par Value	Disposition	2018-05-07	1,312	$350.02	48,157	No	4	S	Direct
Common Stock, $.01 Par Value	Disposition	2018-05-07	1,000	$350.88	47,157	No	4	S	Direct
Common Stock, $.01 Par Value	Disposition	2018-05-07	200	$351.97	46,957	No	4	S	Direct
Common Stock, $.01 Par Value	Disposition	2018-05-07	200	$352.78	46,757	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2018-05-07	17,500	$0.00	17,500	$21.55

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
7,500	2015-05-14	2024-05-14	No	4	M	Direct

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Date	Expiration Date	Remaning Holdings	Nature of Ownership
Common Stock	Stock Option (Right to Buy)	$23.15	2014-05-14	2023-05-14	25,000	Direct
Common Stock	Stock Option (Right to Buy)	$66.25	2016-05-13	2025-05-13	5,000	Direct
Common Stock	Stock Option (Right to Buy)	$99.62	2017-05-24	2026-05-24	8,000	Direct
Common Stock	Stock Option (Right to Buy)	$134.51	2018-05-15	2027-05-15	6,500	Direct

Expiration Date	Remaning Holdings	Nature of Ownership
2023-05-14	25,000	Direct
2025-05-13	5,000	Direct
2026-05-24	8,000	Direct
2027-05-15	6,500	Direct

Footnotes

Grant to reporting person of option to buy the number of shares of common stock set forth on Table II, Column 7, under the Abiomed, Inc. 2008 Stock Incentive Plan.
These options become exerciseable in annual 25% increments, commencing on the date shown forth in Table II, Column 6.
These options become exercisable in annual 33-1/3% increments, commencing on the date shown in Table II, Column 6.
Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2015 Omnibus Incentive Plan.
Exercise of stock options pursuant to reporting owner's 10b5-1 plan.
Sale of common stock pursuant to reporting owner's 10b5-1 plan.
This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $344.5600 and $345.4700. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $345.6100 and $346.5500. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $346.5600 and $347.5500. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $347.6500 and $348.5300. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $348.6800 and $349.4500. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $349.6600 and $350.4100. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $350.7100 and $350.9800. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.